|
|
|
Directors
Leonard P. Shaykin
Chairman of the Board and Chief Executive Officer
Stephen K. Carter, M.D.
3,4*
Former Senior Vice President, Worldwide Clinical Research and Development, Bristol-Myers Squibb and Deputy Director, Division of Cancer Treatment, National Cancer Institute
George M. Gould, Esq.
1*,2,3
Attorney, Of Counsel, Gibbons, Del Deo, Dolan, Griffinger & Vecchione; Formerly Vice President and Chief Patent Counsel of Hoffman-La Roche
Arthur Hull Hayes, Jr., M.D.
1,4
President, MediScience Associates, a pharmaceutical consulting company; Formerly FDA Commissioner
The Honorable Richard N. Perle
2
A Director of Hollinger International; Vital Spring Technologies; Autonomy, PLC; Formerly U.S. Assistant Secretary of Defense
Robert E. Pollack, Ph.D.
3*,4*
Professor of Biological Sciences and Director of the Center for the Study of Science and Religion at Columbia University
Elliot Maza, J.D., CPA
2*,3
President and Chief Financial Officer of Intellect Neurosciences; formerly Partner at
Ernst & Young and employed at Goldman Sachs & Co, and J.P. Morgan Securities
EXECUTIVE OFFICERS
Leonard P. Shaykin
Chairman of the Board, Chief Executive Officer
Martin Batt
Senior Vice President, Chief Operating Officer
Gordon Link, Jr.
Senior Vice President, Chief Financial Officer
Kai P. Larson
Vice President, General Counsel
Committee Assignments
1Nominating and Corporate Governance Committee
2Audit Committee
3Compensation Committee
4Research and Development Committee
*Chairman
|
|
|
